Page last updated: 2024-09-03

tak 044 and enalapril

tak 044 has been researched along with enalapril in 1 studies

Compound Research Comparison

Studies
(tak 044)
Trials
(tak 044)
Recent Studies (post-2010)
(tak 044)
Studies
(enalapril)
Trials
(enalapril)
Recent Studies (post-2010) (enalapril)
105826,3111,924859

Protein Interaction Comparison

ProteinTaxonomytak 044 (IC50)enalapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.3536
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)2.7083
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)1.2
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.14
Angiotensin-converting enzyme 2 Homo sapiens (human)0.14

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davenport, AP; Dhaun, N; Ferro, CJ; Goddard, J; Haynes, WG; Webb, DJ1

Trials

1 trial(s) available for tak 044 and enalapril

ArticleYear
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11

    Topics: Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Doxazosin; Enalapril; Endothelin Receptor Antagonists; Furosemide; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Peptides, Cyclic; Prospective Studies

2007
chemdatabank.com